Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linda Henry

Showing results (271-280 of 280) with videos related to

Pageof 28
Sort By:
You have reached the last page of results.This site can display upto 280 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 29, 2019
Hepatitis C Virus Cure Rates Are Reduced in Patients With Active but Not Inactive Hepatocellular Carcinoma: A Practice ImplicationEiichi Ogawa, Hidenori Toyoda, Etsuko Iio, et al.
The Journal of Infectious Diseases|September 25, 2019
Real-World Effectiveness From the Asia Pacific Rim Liver Consortium for HBV Risk Score for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated With Oral Antiviral TherapyHwai-I Yang, Ming-Lun Yeh, Grace L Wong, et al.
Hepatology (Baltimore, Md.)|June 25, 2025
Type 2 diabetes mellitus as an independent predictor of significant fibrosis in treatment-naïve chronic hepatitis B patients with concurrent hepatic steatosisJie Li, Liang Xu, Fajuan Rui, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 10, 2025
Projected Global Clinical, Humanistic, and Economic Impact of Metabolic Dysfunction-Associated Steatohepatitis (MASH): The Cost of Inaction Based on Data From Nine CountriesZobair M Younossi, James M Paik, Jeffrey V Lazarus, et al.
Gastroenterology|April 13, 2025
Global Consensus Recommendations for Metabolic Dysfunction-Associated Steatotic Liver Disease and SteatohepatitisZobair M Younossi, Shira Zelber-Sagi, Jeffrey V Lazarus, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 8, 2026
Updated Global Consensus Recommendations for Risk Stratification, Treatment Initiation, and Response Monitoring in Metabolic Dysfunction-Associated Steatotic Liver DiseaseZobair M Younossi, Markos Kalligeros, Vincent Wai-Sun Wong, et al.
Journal of Hepatology|November 20, 2023
Global survey of stigma among physicians and patients with nonalcoholic fatty liver diseaseZobair M Younossi, Saleh A Alqahtani, Khalid Alswat, et al.
JHEP Reports : Innovation in Hepatology|July 18, 2024
The impact of stigma on quality of life and liver disease burden among patients with nonalcoholic fatty liver diseaseZobair M Younossi, Saleh A AlQahtani, Jesús Funuyet-Salas, et al.
The American Journal of Gastroenterology|June 14, 2026
Higher incidence of hepatocellular carcinoma in suppressed hepatitis B cirrhosis compared to cured hepatitis C cirrhosisJiyoon Park, Sally Tran, Eiichi Ogawa, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 22, 2026
Long-Term Mortality Following Hepatitis C Cure in a Real-World Multinational CohortFanpu Ji, Sally Tran, Hidenori Toyoda, et al.
Pageof 28

Showing results (271-280 of 280) with videos related to

Sort By:
Pageof 28
You have reached the last page of results.This site can display upto 280 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 29, 2019
Hepatitis C Virus Cure Rates Are Reduced in Patients With Active but Not Inactive Hepatocellular Carcinoma: A Practice ImplicationEiichi Ogawa, Hidenori Toyoda, Etsuko Iio, et al.
The Journal of Infectious Diseases|September 25, 2019
Real-World Effectiveness From the Asia Pacific Rim Liver Consortium for HBV Risk Score for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated With Oral Antiviral TherapyHwai-I Yang, Ming-Lun Yeh, Grace L Wong, et al.
Hepatology (Baltimore, Md.)|June 25, 2025
Type 2 diabetes mellitus as an independent predictor of significant fibrosis in treatment-naïve chronic hepatitis B patients with concurrent hepatic steatosisJie Li, Liang Xu, Fajuan Rui, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 10, 2025
Projected Global Clinical, Humanistic, and Economic Impact of Metabolic Dysfunction-Associated Steatohepatitis (MASH): The Cost of Inaction Based on Data From Nine CountriesZobair M Younossi, James M Paik, Jeffrey V Lazarus, et al.
Gastroenterology|April 13, 2025
Global Consensus Recommendations for Metabolic Dysfunction-Associated Steatotic Liver Disease and SteatohepatitisZobair M Younossi, Shira Zelber-Sagi, Jeffrey V Lazarus, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 8, 2026
Updated Global Consensus Recommendations for Risk Stratification, Treatment Initiation, and Response Monitoring in Metabolic Dysfunction-Associated Steatotic Liver DiseaseZobair M Younossi, Markos Kalligeros, Vincent Wai-Sun Wong, et al.
Journal of Hepatology|November 20, 2023
Global survey of stigma among physicians and patients with nonalcoholic fatty liver diseaseZobair M Younossi, Saleh A Alqahtani, Khalid Alswat, et al.
JHEP Reports : Innovation in Hepatology|July 18, 2024
The impact of stigma on quality of life and liver disease burden among patients with nonalcoholic fatty liver diseaseZobair M Younossi, Saleh A AlQahtani, Jesús Funuyet-Salas, et al.
The American Journal of Gastroenterology|June 14, 2026
Higher incidence of hepatocellular carcinoma in suppressed hepatitis B cirrhosis compared to cured hepatitis C cirrhosisJiyoon Park, Sally Tran, Eiichi Ogawa, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 22, 2026
Long-Term Mortality Following Hepatitis C Cure in a Real-World Multinational CohortFanpu Ji, Sally Tran, Hidenori Toyoda, et al.
Pageof 28